Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The drug-induced phenotypic landscape of colorectal cancer organoids.
Betge J, Rindtorff N, Sauer J, Rauscher B, Dingert C, Gaitantzi H, Herweck F, Srour-Mhanna K, Miersch T, Valentini E, Boonekamp KE, Hauber V, Gutting T, Frank L, Belle S, Gaiser T, Buchholz I, Jesenofsky R, Härtel N, Zhan T, Fischer B, Breitkopf-Heinlein K, Burgermeister E, Ebert MP, Boutros M. Betge J, et al. Among authors: hartel n. Nat Commun. 2022 Jun 6;13(1):3135. doi: 10.1038/s41467-022-30722-9. Nat Commun. 2022. PMID: 35668108 Free PMC article.
Checkpoints and beyond - Immunotherapy in colorectal cancer.
Gutting T, Burgermeister E, Härtel N, Ebert MP. Gutting T, et al. Among authors: hartel n. Semin Cancer Biol. 2019 Apr;55:78-89. doi: 10.1016/j.semcancer.2018.04.003. Epub 2018 Apr 30. Semin Cancer Biol. 2019. PMID: 29716829 Review.
Aryl hydrocarbon receptor nuclear translocator-like (ARNTL/BMAL1) is associated with bevacizumab resistance in colorectal cancer via regulation of vascular endothelial growth factor A.
Burgermeister E, Battaglin F, Eladly F, Wu W, Herweck F, Schulte N, Betge J, Härtel N, Kather JN, Weis CA, Gaiser T, Marx A, Weiss C, Hofheinz R, Miller IS, Loupakis F, Lenz HJ, Byrne AT, Ebert MP. Burgermeister E, et al. Among authors: hartel n. EBioMedicine. 2019 Jul;45:139-154. doi: 10.1016/j.ebiom.2019.07.004. Epub 2019 Jul 9. EBioMedicine. 2019. PMID: 31300350 Free PMC article.
Outcome of Colorectal Cancer Patients Treated with Combination Bevacizumab Therapy: A Pooled Retrospective Analysis of Three European Cohorts from the Angiopredict Initiative.
Betge J, Barat A, Murphy V, Hielscher T, Van Grieken NC, Belle S, Zhan T, Härtel N, Kripp M, Bacon O, Cordes M, Kay EW, Verheul HM, Neerincx M, Hennessy B, Hofheinz RD, Gaiser T, Ylstra B, Prehn JH, Lambrechts D, Byrne AT, Ebert MP, Schulte N. Betge J, et al. Among authors: hartel n. Digestion. 2016;94(3):129-137. doi: 10.1159/000449412. Epub 2016 Oct 19. Digestion. 2016. PMID: 27756074
Epigenetic silencing of tumor suppressor candidate 3 confers adverse prognosis in early colorectal cancer.
Burgermeister E, Höde P, Betge J, Gutting T, Merkel A, Wu W, Tänzer M, Mossner M, Nowak D, Magdeburg J, Rückert F, Sticht C, Breitkopf-Heinlein K, Schulte N, Härtel N, Belle S, Post S, Gaiser T, Heppner BI, Behrens HM, Röcken C, Ebert MPA. Burgermeister E, et al. Among authors: hartel n. Oncotarget. 2017 Sep 15;8(49):84714-84728. doi: 10.18632/oncotarget.20950. eCollection 2017 Oct 17. Oncotarget. 2017. PMID: 29156678 Free PMC article.
Neglected geriatric assessment and overtreatment of older patients with pancreatic cancer - Results from a prospective phase IV clinical trial.
Betge J, Schulte N, Belle S, Zhan T, Krammer-Steiner B, Moulin JC, Kleiß M, Lammert F, Wedding U, Räth S, Maenz M, Hegele L, Larcher-Senn J, Jesenofsky R, Ebert MP, Härtel N. Betge J, et al. Among authors: hartel n. J Geriatr Oncol. 2022 Jun;13(5):662-666. doi: 10.1016/j.jgo.2021.12.018. Epub 2022 Jan 3. J Geriatr Oncol. 2022. PMID: 34991998 Clinical Trial.
[Gastrointestinal tumors in older patients].
Schulte N, Ebert MP, Reissfelder C, Härtel N. Schulte N, et al. Among authors: hartel n. Z Gastroenterol. 2020 Jun;58(6):564-576. doi: 10.1055/a-1149-2282. Epub 2020 Jun 16. Z Gastroenterol. 2020. PMID: 32544966 German.
31 results